Literature DB >> 19879229

Declining invasive pneumococcal disease mortality in the United States, 1990-2005.

Marifi Pulido1, Frank Sorvillo.   

Abstract

PCV7 use in the U.S. has led to notable decreases in invasive pneumococcal disease (IPD). We examined PCV7 influence on IPD mortality for all age groups using National Multiple-Cause-of-Death data (1990-2005). Age-specific mortality rates were compared before and after PCV7 use. Average decreases in age-adjusted mortality rates for meningitis and septicemia accelerated post-PCV7, the greatest decline observed in septicemia-related deaths. The youngest and oldest age groups experienced large decreases in age-specific mortality rates after the introduction of PCV7. Mortality rate decline across all age groups strengthens evidence of vaccine-induced herd immunity and provides additional information for cost-benefit analyses of PCV7.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879229     DOI: 10.1016/j.vaccine.2009.10.121

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

Review 1.  Interventions to improve influenza and pneumococcal vaccination rates among community-dwelling adults: a systematic review and meta-analysis.

Authors:  Darren Lau; Jia Hu; Sumit R Majumdar; Dale A Storie; Sandra E Rees; Jeffrey A Johnson
Journal:  Ann Fam Med       Date:  2012 Nov-Dec       Impact factor: 5.166

Review 2.  Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.

Authors:  Tina Q Tan
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Surveillance of bacterial meningitis in the country of Georgia, 2006-2010.

Authors:  Maia Butsashvili; George Kandelaki; Medea Eloshvili; Rusudan Chlikadze; Paata Imnadze; Nata Avaliani
Journal:  J Community Health       Date:  2013-08

4.  Clinical and Epidemiological Evidence of the Red Queen Hypothesis in Pneumococcal Serotype Dynamics.

Authors:  Chris Stockmann; Krow Ampofo; Andrew T Pavia; Anne J Blaschke; Edward O Mason; Angela P Presson; Larry J Forney; Carrie L Byington
Journal:  Clin Infect Dis       Date:  2016-06-09       Impact factor: 9.079

5.  Immunization, Antibiotic Use, and Pneumococcal Colonization Over a 15-Year Period.

Authors:  Grace M Lee; Ken Kleinman; Stephen Pelton; Marc Lipsitch; Susan S Huang; Matt Lakoma; Maya Dutta-Linn; Melisa Rett; William P Hanage; Jonathan A Finkelstein
Journal:  Pediatrics       Date:  2017-10-04       Impact factor: 7.124

Review 6.  Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children.

Authors:  Matt Wasserman; Ruth Chapman; Rotem Lapidot; Kelly Sutton; Desmond Dillon-Murphy; Shreeya Patel; Erica Chilson; Vincenza Snow; Raymond Farkouh; Stephen Pelton
Journal:  Emerg Infect Dis       Date:  2021       Impact factor: 6.883

7.  The status of invasive pneumococcal disease among children younger than 5 years of age in north-west Lombardy, Italy.

Authors:  Enrica Riva; Filippo Salvini; Maria Laura Garlaschi; Giovanni Radaelli; Marcello Giovannini
Journal:  BMC Infect Dis       Date:  2012-05-03       Impact factor: 3.090

Review 8.  Streptococcus pneumoniae serotype 19A in Latin America and the Caribbean: a systematic review and meta-analysis, 1990-2010.

Authors:  Elizabeth Castañeda; Clara Inés Agudelo; Rodrigo De Antonio; Diego Rosselli; Claudia Calderón; Eduardo Ortega-Barria; Rómulo E Colindres
Journal:  BMC Infect Dis       Date:  2012-05-28       Impact factor: 3.090

9.  Prevalence and clonal distribution of pcpA, psrP and Pilus-1 among pediatric isolates of Streptococcus pneumoniae.

Authors:  Laura Selva; Pilar Ciruela; Krystle Blanchette; Eva del Amo; Roman Pallares; Carlos J Orihuela; Carmen Muñoz-Almagro
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.